Computational analysis of benzofuran-2-carboxlic acids as potent Pim-1 kinase inhibitors

Pharmaceutical Biology

Volumn 52, Issue 9, 2014, Pages 1170-1178

  Wadood, Abdul ^a   Jamal, Syed Babar ^a   Riaz, Muhammad ^a   Mir, Asif ^b  

^a ABDUL WALI KHAN UNIVERSITY   (Pakistan)

^b INTERNATIONAL ISLAMIC UNIVERSITY   (Pakistan)

Author keywords

Cancer and inhibitor; Molecular docking; Pim kinase

Indexed keywords

BENZOFURAN 2 CARBOXYLIC ACID DERIVATIVE; CARBOXYLIC ACID DERIVATIVE; PROTEIN KINASE INHIBITOR; PROTEIN KINASE PIM 1; UNCLASSIFIED DRUG; BENZOFURAN DERIVATIVE; CARBOXYLIC ACID; LIGAND;

ACIDITY; ARTICLE; COMPUTER PROGRAM; CORRELATION ANALYSIS; CRYSTALLIZATION; DRUG DESIGN; DRUG PROTEIN BINDING; DRUG STRUCTURE; ENZYME ACTIVE SITE; ENZYME BINDING; ENZYME INHIBITION; MOLECULAR DOCKING; PREDICTION; PROSTATE CANCER; ANTAGONISTS AND INHIBITORS; CHEMISTRY;

BENZOFURANS; CARBOXYLIC ACIDS; CRYSTALLIZATION; DRUG DESIGN; LIGANDS; MOLECULAR DOCKING SIMULATION; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-PIM-1;

EID: 84906053714     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2014.880488     Document Type: Article

References (17)

1. Aho TLT, Sandholm J, Peltola KJ, et al. (2004). Pim-1 kinase promotes inactivation of the pro-apoptotic Bad protein by phosphorylating it on the Serl 12 gatekeeper site. FEBS Lett 571:43-9.
2. Allen JD, Verhoeven E, Domen J, et al. (1997). Pim-2 transgene induces lymphoid tumors, exhibiting potent synergy with c-myc. Oncogene 15:1133-41.
3. Amaravadi R, Thompson CB. (2005). The survival kinases Akt and Pim as potential pharmacological targets. J Clin Invest 115:2618-24.
4. Bachmann M, Moroy T. (2005). The serine/threonine kinase Pim-1. Int J Biochem Cell Biol 37:726-30.
5. Cibull TL, Jones TD, Li L, et al. (2006). Overexpression of Pim-1 during progression of prostatic adenocarcinoma. J Clin Pathol 59:285-8.
6. Dai H, Li R, Wheeler T, et al. (2005). Pim-2 upregulation: Biological implications associated with disease progression and perinueral invasion in prostate cancer. Prostate 65:276-86.
7. Eichmann A, Yuan L, Breant C, et al. (2000). Developmental expression of pim kinases suggests functions also outside of the hematopoietic system. Oncogene 19:1215-24.
8. Geromichalos GD. (2007). Importance of molecular computer modeling in anticancer drug development. J BUON 1:S101-18.
9. Li YY, Popivanova BK, Nagai Y, et al. (2006). Pim-3, a proto-oncogene with serin/theronine kinase activity, is aberrantly expressed in human pancreatic cancer and phosphorylates bad to block bad-mediated apoptosis in human pancreatic cancer cell lines. Cancer Res 66: 6741-7.
10. Morishita D, Katayama R, Sekimizu K, et al. (2008). Pim kinases promote cell cycle progression by phosphorylating and downregulating p27KipI at the transcriptional and posttranscriptional levels. Cancer Res 68:5076-85.
11. Morishita D, Takami M, Yoshikawa S, et al. (2011). Cell-permeable carboxyl-terminal p27Kip1 peptide exhibits anti-tumor activity by inhibiting Pim-1 kinase. J Biol Chem 286:2681-8.
12. Nawijn MC, Alendar A, Berns A. (2011). For better or for worse: The role of Pim oncogenes in tumorigenesis. Nat Rav Cancer 11:23-34.
13. Popivanova BK, Li YY, Zheng H, et al. (2007). Proto-oncogenes, Pim-3 with serine/threonine kinase activity, is aberrantly expressed in colon cancer cells and can prevent Bad-mediated apoptosis. Cancer Sci 98: 321-8.
14. Siu A, Virtanen C, Jongstra J. (2011). Pim kinase isoform specific regulation of MIG6 expression and EGFR signaling in prostate cancer. Oncotarget 2:1134-44.
15. Wadood A, Riaz M, Jamal SB, et al. (2013). Molecular docking study of P4-benzoxaborole substituted ligands as inhibitors of HCV NS3/4A protease. Bioinformation 9:309-14.
16. Wu Y, Wang YY, Nakamota Y, et al. (2010). Accelerated hepatocellular carcinoma development in mice expression the Pim-3 transgene selectively in the liver. Oncogene 29:2228-37.
17. Xiang Y, Hirth B, Asmussen G, et al. (2011). The discovery of novel benzofuran-2-carboxylic acids as potent Pim-1 inhibitors. Bioorg Med Chem Lett 21:3050-6.